Glenn Mattes is the founder of TFF. Backed by Ascend Capital. Funding history, background and contact routes on StartupFundraising.com.
Glenn Mattes is the President and CEO of TFF Pharmaceuticals, a clinical-stage biopharmaceutical company. He has been with the company since its inception and oversees its preclinical development milestones and the progression of lead compounds into Phase 1 clinical trials.
Full founder directory · Investor directory · Company funding database · Fundraising library